Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention

NCT03378934 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Percutaneous Coronary Intervention

Interventions

DRUG: Berberine
DRUG: Standard treatment
DRUG: Aspirin
DRUG: Clopidogrel

Sponsor

Peking Union Medical College Hospital